Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
10/23/2008 | US20080262246 Novel chemical intermediates; reacting with organometallic compound |
10/23/2008 | US20080262224 Method of Preparation of Benzofuran-2-Carboxylic Acid -Amide |
10/23/2008 | US20080262139 A novolak structure modified by nitrogen-containing or silicon-containing compound may collocate with inorganic powder; high heat resistance and glass transition temperature, low expansion, hydrophobic; prepregs used in copper clad laminates or printed circuit plates |
10/23/2008 | US20080262082 S-(-)-tulipalin B, acetylated-S-(-)-tulipalin B and an antibacterial composition comprising the same. The active compound tulipalin B and composition of the present invention exhibit superior and stable antibacterial activity over a broad range of temperature and pH |
10/23/2008 | US20080262032 Isoxazoline Derivative and Novel Process for Its Preparation |
10/23/2008 | US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
10/23/2008 | US20080261993 surprisingly active in the control of insects and acarids; admixture with pesticides, plant growth regulators, fertilizers and soil conditioners |
10/23/2008 | US20080261967 Modulators of Central Nervous System Neurotransmitters |
10/23/2008 | DE102007018148A1 Preparation of alkene, which is a polymer compound, preferably homopolymer, copolymer or block-copolymer, comprises metathesis reaction of unsaturated compound containing an alkene or alkyne unit in the presence of an active catalyst |
10/22/2008 | EP1982976A1 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof |
10/22/2008 | EP1981867A2 Method for preparing prostaglandin derivative |
10/22/2008 | EP1981866A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
10/22/2008 | EP1981865A1 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia |
10/22/2008 | EP1981864A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
10/22/2008 | EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
10/22/2008 | EP1706394A4 Preparation of escitalopram |
10/22/2008 | CN101292039A Method for producing cercosporamide |
10/22/2008 | CN101289438A 3-(3í»-hydroxyl)-butyl phthalide ester, and preparation thereof and uses |
10/22/2008 | CN101289437A Process for separating gibberellin A4 from the mixture of gibberellin A4 and A7 |
10/22/2008 | CN101289436A Process for preparing furfural |
10/22/2008 | CN101289435A Process for preparing 5-hydroxymethyl-furfural |
10/22/2008 | CN101289434A 1,5-difuranyl pentadienones, preparation method and sterilization activity thereof |
10/22/2008 | CN101289433A Method for preparing alpha, beta-2-dibrom furan chlcones and sterilization activity thereof |
10/22/2008 | CN100427482C N,N-dimethylaminoacyl-2,3-difuryl-6-aminoquinoxaline, preparation method and application thereof |
10/22/2008 | CN100427472C Aryl-heteroaromatic products, compositions containing same and use thereof |
10/21/2008 | US7439373 X-ray powder diffraction; antitumor agents |
10/21/2008 | US7439368 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
10/21/2008 | US7439266 Malononitrile compound and use thereof |
10/21/2008 | CA2146707C Substituted n-heteroaroylguanidines as inhibitors of na+/h+ exchange |
10/16/2008 | WO2008123469A1 Six-membered amide compound and use thereof |
10/16/2008 | WO2008123349A1 Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative |
10/16/2008 | WO2008123067A1 Method for asymmetric hydrogenation of allyl amine |
10/16/2008 | WO2008083950A3 Spirocyclic tetronic acid derivatives |
10/16/2008 | WO2008048668A3 Novel inhibitors of chymase |
10/16/2008 | WO2008024302A3 Compounds for treating proliferative disorders |
10/16/2008 | US20080255377 Processes for the Manufacture of Chiral and Racemic Forms of 3-Aminotetrahydrofurans, Their Salts and Derivatives |
10/16/2008 | US20080255374 Process for charging a longitudinal section of a catalyst tube |
10/16/2008 | US20080255230 Pain therapy; muscular disorders; diarrhea |
10/16/2008 | US20080255221 Novel hydroxamates as therapeutic agents |
10/16/2008 | US20080255214 Novel hydroxamates as therapeutic agents |
10/16/2008 | US20080255198 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
10/16/2008 | US20080255152 Diaryl ethers as opioid receptor antagonists |
10/16/2008 | US20080255144 (3'-Chloro-4-methanesulfonyl-biphenyl-2-yl)-[4-(3,4-dichloro-phenyl)-piperazin-1-yl]-methanone; neurological and neuropsychiatric disorders including schizophrenia |
10/16/2008 | US20080255126 Inhibitors of post-proline cleaving proteases |
10/16/2008 | US20080255042 CaSR Antagonist |
10/16/2008 | US20080254520 By controlling level of carbohydrates (starch, molasses) during Penicillium biodegradation; crystalline E-8-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-isobenzofuran-5-yl)-2,6-dimethyl-oct-6-enoic acid |
10/15/2008 | EP1979311A2 Phenoxy acetic acids as ppar delta activators |
10/15/2008 | EP1763506B1 Method for producing nitriles by elimination of water from aldehyde oximes with alkylphosphonic anhydrides |
10/15/2008 | EP1716108B1 Method for the separation of intermediates which may be used for the preparation of escitalopram |
10/15/2008 | EP1692124B1 Biaryl sulfonamides as mmp inhibitors |
10/15/2008 | EP1308436B1 Calcium receptor antagonists |
10/15/2008 | EP1142872B1 Aromatic heterocycle compounds having hiv integrase inhibiting activities |
10/15/2008 | EP0923544B1 Method for the synthesis of amines and amino acids with organoboron derivatives |
10/15/2008 | CN101287719A Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
10/15/2008 | CN101284825A Synthetic method of tetramethylene maleic anhydride |
10/15/2008 | CN101284824A Preparation method of cenolate |
10/15/2008 | CN101284823A Arctigenin pro-drug, preparation method and use thereof |
10/15/2008 | CN101284808A Compounds and methods for the inhibition of the expression of VCAM-1 |
10/15/2008 | CN101284755A Chemical synthesis process for conjugated alkenes compounds |
10/15/2008 | CN101284242A Catalyst for producing maleic anhydrid(e) by benzene gas-phase oxidation with high load and high yield |
10/15/2008 | CN101283998A Application of bromine phenolic compound in preparing the medicine for curing the malignancy |
10/15/2008 | CN101283997A Application of bromine phenolic compound in preparing the medicine for curing the ischemic cardio-vascular and cerebrovascular diseases |
10/15/2008 | CN100425604C Process for supersonically extracting usnic acid |
10/15/2008 | CN100425603C Compound with anti cerebralischemia, myo cardialischemia and memory-improving functions, and its preparing method and use |
10/15/2008 | CN100425602C Diamine, acid dianhydride, polyimide composition having reactive group obtained therefrom, and processes for producing these |
10/14/2008 | US7435843 Thiobenzoic acid, N-malonylhydrazide in which the free carboxy group is protected; enhances the desirable tumor attacking properties of anticancer agents without further increasing undesirable side-effects |
10/14/2008 | US7435838 Mixture of both S- and R-enantiomers of 3-hydroxymethyl-4-[1-(p-fluorophenyl)-1-hydroxyl-4-(dimethylamino)]butylbenzonitrile; dissolving the intermediate free base oil in a single- or multi-component solvent, and crystallizing one or more times |
10/14/2008 | US7435837 Serotonin receptors agonists; central nervous system disorders; schizophrenia, anxiety disorders, bipolar disorders, obesity; 1-[7-(2,3-dimethylphenyl)-2,3-dihydro-1-benzofuran-2-yl]methanamine; side effect reduction; antipsychotic |
10/14/2008 | US7435756 Preparation and diabetic use of gibberellins |
10/14/2008 | US7435318 Adding entrainers such as 1-ethyl-3-methylimidazolium tetrafluoroborate to liquid mixtures, then distilling the mixtures; efficiency |
10/14/2008 | CA2309328C Cyclic amine derivatives and their use as drugs |
10/09/2008 | WO2008120093A1 Sulfonamides and pharmaceutical compositions thereof |
10/09/2008 | WO2008024304A3 Compounds for treatment of proliferative disorders |
10/09/2008 | US20080249319 Process for the preparation of 5-Carboxyphthalide |
10/09/2008 | US20080249252 New permanent surface modifiers |
10/09/2008 | US20080249119 Nucleosiding a protected cytosine with a protected hexose, deprotecting to obtain gemcitabine; administering as produgs; cancers of the lungs, ovaries, pancreas and bladder; cost efficiency; simplification |
10/09/2008 | US20080249107 Comprising trihydroxy phenyl subunits; selectin inhibitors; side effect reduction; 3-{3-[3-(3,4,5-Trihydroxy-phenyl)-propionylamino]-phenylamino}-benzoic acid |
10/08/2008 | EP1978012A1 Alternative synthesis of renin inhibitors and intermediates thereof |
10/08/2008 | EP1977646A1 Insecticidal hydroxyethyl thlourea derivatives |
10/08/2008 | EP1976839A2 Compounds and methods for modulating protein trafficking |
10/08/2008 | EP1976827A2 Method for producing methionine from homoserine |
10/08/2008 | EP1976382A2 Process for preparing a synthetic intermediate for preparation of branched nucleosides |
10/08/2008 | EP1539693B9 Cannabinoid receptor agonists |
10/08/2008 | EP1352904B1 (meth)acrylate esters, starting alcohols for the preparation thereof, processes for preparing both, polymers of the esters, chemically amplifiable resist compositions, and method for forming patterns |
10/08/2008 | CN101282957A 新的药物化合物 New pharmaceutical compounds |
10/08/2008 | CN101282956A Anti-malarial compound isolated from gomphostema niveum |
10/08/2008 | CN101282933A Novel NK1 and NK2 antagonists |
10/08/2008 | CN101279964A Guaiane type sesquiterpenes, preparation and medical use thereof |
10/08/2008 | CN101279963A Preparation of darifenacin intermediate 5-(halogenated ethyl)-2,3-dihydrobenzofuran |
10/08/2008 | CN101279962A Method for preparing L-ascorbyl palmitate from biodiesel by-product |
10/08/2008 | CN100424062C Process for preparing hydroaromatic polybasic carboxylic acid and process for preparing hydroaromatic polybasic carboxylic anhydride |
10/07/2008 | US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques |
10/07/2008 | US7432382 Conversion of 2,5-(hydroxymethyl)furaldehyde to industrial derivatives, purification of the derivatives, and industrial uses therefor |
10/07/2008 | US7432303 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
10/07/2008 | US7432302 Treating proliferative cutaneous disease using a polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; e.g. lupus; use with other biosynthesis enzyme inhibitors |
10/07/2008 | US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944 |
10/07/2008 | US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
10/07/2008 | US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
10/07/2008 | US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain |
10/07/2008 | US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |